Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. (Q50607902)
Jump to navigation
Jump to search
scientific article published on 15 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. |
scientific article published on 15 October 2014 |
Statements
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial. (English)
1 reference
1 reference
1 reference
1 reference
Peter M Ellis
1 reference
Frances A Shepherd
1 reference
Michael Millward
1 reference
Francesco Perrone
1 reference
Lesley Seymour
1 reference
Sophie Sun
1 reference
Byoung Chul Cho
1 reference
Natasha B Leighl
1 reference
Martin R Stockler
1 reference
Christopher W Lee
1 reference
Rafal Wierzbicki
1 reference
Victor Cohen
1 reference
Normand Blais
1 reference
Randeep S Sangha
1 reference
Jin Hyoung Kang
1 reference
Carolyn F Wilson
1 reference
Zelanna Goldberg
1 reference
Keyue Ding
1 reference
Glenwood D Goss
1 reference
Penelope Ann Bradbury
1 reference
NCIC CTG
1 reference
Australasian Lung Cancer Trials Group
1 reference
NCI Naples Clinical Trials Unit
1 reference
15 October 2014
1 reference
15
1 reference
12
1 reference
1379-1388
1 reference
Identifiers
1 reference